Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension.

Our real-world data suggest that residual risk can be captured by noninvasive clinical procedures during routine follow-up assessments in patients with PAH and highlights the potential use of echocardiographic imaging to refine risk assessment.